|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,443 |
$50,345.95 |
2.77% |
| Steris Plc |
STE |
G8473T100 |
224 |
$49,430.08 |
2.72% |
| Alcon Inc. |
ALC.SW |
H01301128 |
579 |
$45,248.21 |
2.49% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,055 |
$45,201.69 |
2.49% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
156 |
$44,358.60 |
2.44% |
| Boston Scientific Corporation |
BSX |
101137107 |
806 |
$43,499.82 |
2.40% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
625 |
$43,456.25 |
2.40% |
| Becton, Dickinson and Company |
BDX |
075887109 |
163 |
$43,201.52 |
2.38% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
115 |
$43,044.50 |
2.37% |
| Medtronic Plc |
MDT |
G5960L103 |
517 |
$41,597.82 |
2.29% |
| Danaher Corporation |
DHR |
235851102 |
166 |
$41,438.58 |
2.28% |
| Cochlear Limited |
COH.AU |
Q25953102 |
250 |
$40,801.87 |
2.25% |
| Stryker Corporation |
SYK |
863667101 |
143 |
$40,676.35 |
2.24% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$40,386.73 |
2.23% |
| Abbott Laboratories |
ABT |
002824100 |
401 |
$39,670.93 |
2.19% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,430 |
$39,651.22 |
2.19% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,652 |
$38,660.07 |
2.13% |
| BioMerieux |
BIM.FP |
F1149Y232 |
391 |
$37,475.38 |
2.07% |
| Penumbra, Inc. |
PEN |
70975L107 |
150 |
$37,554.00 |
2.07% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,159 |
$37,452.54 |
2.06% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
271 |
$37,205.98 |
2.05% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
315 |
$37,107.00 |
2.05% |
| Baxter International Inc. |
BAX |
071813109 |
969 |
$36,928.59 |
2.04% |
| The Cooper Companies, Inc. |
COO |
216648402 |
112 |
$36,779.68 |
2.03% |
| Align Technology, Inc. |
ALGN |
016255101 |
122 |
$36,634.16 |
2.02% |
| Waters Corporation |
WAT |
941848103 |
136 |
$36,566.32 |
2.02% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
71 |
$35,612.89 |
1.96% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,772 |
$35,272.64 |
1.94% |
| Hologic, Inc. |
HOLX |
436440101 |
496 |
$34,754.72 |
1.92% |
| DENTSPLY SIRONA Inc. |
XRAY |
24906P109 |
1,014 |
$34,638.24 |
1.91% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$34,739.10 |
1.91% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
709 |
$34,370.00 |
1.89% |
| Revvity, Inc. |
RVTY |
714046109 |
304 |
$32,980.96 |
1.82% |
| Agilent Technologies, Inc. |
A |
00846U101 |
300 |
$32,919.00 |
1.81% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
301 |
$32,830.57 |
1.81% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,537 |
$32,835.95 |
1.81% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
507 |
$32,392.23 |
1.79% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
134 |
$32,408.78 |
1.79% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
131 |
$32,264.72 |
1.78% |
| DexCom, Inc. |
DXCM |
252131107 |
361 |
$32,157.88 |
1.77% |
| Teleflex Incorporated |
TFX |
879369106 |
158 |
$32,146.68 |
1.77% |
| Shockwave Medical, Inc. |
SWAV |
82489T104 |
161 |
$31,697.68 |
1.75% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
87 |
$31,085.10 |
1.71% |
| Olympus Corporation |
7733.JP |
J61240107 |
2,240 |
$30,480.12 |
1.68% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
578 |
$28,720.36 |
1.58% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
26 |
$28,444.78 |
1.57% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
298 |
$25,351.69 |
1.40% |
| ResMed Inc. |
RMD |
761152107 |
186 |
$25,349.94 |
1.40% |
| Masimo Corporation |
MASI |
574795100 |
218 |
$21,152.54 |
1.17% |
| Insulet Corporation |
PODD |
45784P101 |
131 |
$20,950.83 |
1.15% |
| US Dollar |
$USD |
|
4,424 |
$4,423.78 |
0.24% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|